QCG
BIVV

Quadrant Capital Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Quadrant Capital Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-229
Closed -$7K – 2276
2017
Q4 		$7K Sell
229
-3
-1% -$164 ﹤0.01% 1389
2017
Q3 		$7K Buy
232
+39
+20% +$2.28K ﹤0.01% 1375
2017
Q2 		$6K Sell
193
-10
-5% -$569 ﹤0.01% 1321
2017
Q1 		$6K Buy
+203
New +$10K ﹤0.01% 1298

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Quadrant Capital Group's BIVV Position: Q1 2018 in Review

Quadrant Capital Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 229 shares — an estimated $7K sold.

Quadrant Capital Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $7K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Quadrant Capital Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Quadrant Capital Group sold 229 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $7K.
  • Quadrant Capital Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Quadrant Capital Group's Bioverativ Inc. Common Stock position peaked at $7K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Quadrant Capital Group's 13F filing for Q1 2018, filed 10 May 2018.